Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

BMS pays $475m for Dragonfly’s IL-12 immunotherapy programme

Agreement will focus on development in oncology and haematology

- PMLiVE

A senior level promotion in scientific services at Porterhouse Medical

Porterhouse is delighted to announce the promotion of Emma Conran

Porterhouse Medical Group

- PMLiVE

US states claim Purdue Pharma owes $2.2 trillion over opioid crisis

Company faces new accusations of dishonest marketing tactics

AstraZeneca AZ

AZ scores FDA priority review for new Imfinzi fixed-dose regimen

Four-week dosing schedule offers new flexibility for patients

Roche Basel Switzerland

Roche’s Soliris rival Enspryng bags FDA approval

Drug is second to be approved for the treatment of NMOSD

AstraZeneca AZ

AZ inks deal with EU for 400 million doses of COVID-19 vaccine

Doses will be available to all EU member states at no profit during pandemic

- PMLiVE

Public Health England to be axed over coronavirus response

Report from The Sunday Telegraph details plans to replace agency

- PMLiVE

Has AI been the key to tackling the COVID-19 pandemic?

By Nikolas Kairinos

- PMLiVE

COVID-19 vaccine approval unlikely before November, says US NIH director

US National Institutes of Health Director Francis Collins cautioned against unrealistic timelines

- PMLiVE

UK agrees on COVID-19 vaccine deals with J&J and Novavax

Initial agreement secures 90 million doses

- PMLiVE

Calliditas bets on PBC drug in Genkyotex buyout

Calliditas will acquire 62.7% of company for an initial €20.3m

- PMLiVE

Speed kills

From testing to reopening to vetting scientific articles, we have lost track of time

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links